More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control ...

Explore the potential of the HIV drug Maraviroc in slowing glioblastoma growth as discovered by McMaster University scientists.

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

Brain cells that promote tumor expansion for aggressive cancers such as glioblastoma can be “flipped” to instead inhibit that ...

The chemokine receptors CCR5 and CXCR4 are the two major coreceptors for HIV entry. Numerous efforts have been made to develop a new class of anti-HIV agents that target these coreceptors as an ...

HOUSTON, Texas (KTRK) -- The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, ...

Over the past three decades, there have been amazing advances in treating and preventing HIV. Subscribe to our newsletter for the latest sci-tech news updates. It's now a manageable infection. A ...

Over the past three decades, there have been amazing advances in treating and preventing HIV. It's now a manageable infection. A person with HIV who takes HIV medicine consistently, before their ...